The week in health tech, explained in plain English.Get the free newsletter →
October 30, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Payers

Judge Sends Ballad Health's UnitedHealth MA Suit to Arbitration

A federal judge has dismissed Johnson City, Tennessee-based Ballad Health's lawsuit against UnitedHealth Group, ruling that the two parties must settle their Medicare Advantage payment dispute in arbitration rather than in court, according to Becker's Hospital Review.

Ballad sued UnitedHealth in October, alleging the insurer spent years denying valid claims, delaying payment, and overstating the severity of patient illnesses to boost its own Medicare Advantage reimbursements. The dismissal does not resolve those claims. It shifts them into private arbitration, a process that typically keeps disputes out of public view and away from a jury.

The case reflects growing friction between health systems and Medicare Advantage insurers over denials and slow payment. A number of hospitals have publicly clashed with, or dropped, MA plans they say make payment too difficult. For providers, the ruling is a reminder that arbitration clauses buried in payer contracts can determine where these fights get decided, limiting the leverage of a public lawsuit.

More in Payers

Payers

CMS Releases 2027 Medicare Advantage Star Ratings

CMS released its 2027 Medicare Advantage star ratings on Oct. 8, shaping quality bonus payments and how insurers compete for members.

Why it matters: Star ratings control billions in quality bonus payments that determine how generous Medicare Advantage plans can be.

Payers

Walmart to Make Some GLP-1s Free for Diabetic Workers in 2027

Walmart will make more than 250 medications, including some GLP-1s for Type 2 diabetes, free to employees starting in 2027.

Why it matters: How a major self-insured employer like Walmart structures GLP-1 coverage signals where corporate drug benefits are heading amid soaring demand.

Payers

Patients Are Taking Insurance Denials Straight to the C-Suite

Some patients are overturning insurance denials by emailing insurer CEOs directly, a workaround that exposes deeper flaws in the standard appeals process.

Why it matters: When patients must reach the CEO to get covered care approved, it signals the normal denial and appeals system is failing the people it should serve.